About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Trick T-Cells to Wipe Out Leukemia in a Girl

by Kathy Jones on March 26, 2013 at 8:10 PM
Font : A-A+

 Researchers Trick T-Cells to Wipe Out Leukemia in a Girl

A team of researchers in the United States revealed that they were able to wipe out leukemia in a young girl with her own modified T-cells with the help of a new type of immune cell therapy.

The case study of Emily "Emma" Whitehead, age 7, offers hope for a new path against a stubborn form of leukemia, known as acute lymphoblastic leukemia (ALL), maybe even replacing the need for chemotherapy and bone marrow transplants someday.

Advertisement

But the research in the New England Journal of Medicine also describes an attempt at T cell reprogramming in another child who did not survive, pointing to the need for more research to improve on the therapies being tested.

ALL is the most common form of childhood cancer, and is often curable. However, the two children in this case study had a high-risk type that resists conventional treatments, so their parents enrolled them in the clinical trial.
Advertisement

"Emily remains healthy and cancer-free, 11 months after receiving bioengineered T cells that zeroed in on a target found in this type of leukemia," the University of Pennsylvania said in a statement.

The second child in the two-person case study was a 10-year-old who also showed no evidence of cancer cells for two months after treatment but later suffered a fatal relapse when the cancer returned in the form of leukemia cells that did not harbor the specific cell receptor targeted by the therapy.

"This study describes how these cells have a potent anticancer effect in children," said co-first author Stephan Grupp of The Children's Hospital of Philadelphia, where both patients took part in the clinical trial.

"However, we also learned that in some patients with ALL, we will need to further modify the treatment to target other molecules on the surface of leukemia cells."

The method works by taking some of the patient's own T-cells and re-engineering them to recognize and attack B cells, which have become cancerous and which express a surface protein called CD19.

Without reprogramming, T cells are unable to tackle cancer cells. But when the researchers modified them into CTL019 cells and returned them to the patients, they multiplied by the thousands. In Whitehead, they have persisted for months.

University of Pennsylvania scientists first developed this modified T cell therapy for use in adult patients with a different form of leukemia known as chronic lymphocytic leukemia (CLL).

In 2011, a small trial on three adults showed early success with the method. Two of those adult patients are still in remission more than 2.5 years later.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Leukemia Chronic Myeloid Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma Bone Marrow Transplantation Hairy Cell Leukemia CAR T-Cell Therapy 

Recommended Reading
Leukemia
Encyclopedia section of medindia gives general information about Leukemia...
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess ......
Acute Myeloid Leukemia
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving ......
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is ......
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
CAR T-Cell Therapy
CAR T-cell therapy is a type of gene therapy where the patient’s T-lymphocytes are genetically alter...
Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by ex...
Hairy Cell Leukemia
Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymp...
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Meh...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use